{"id":"https://openalex.org/W2281915918","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2014","title":"Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors","display_name":"Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors","publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W2281915918","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2014","mag":"2281915918"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.2014","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.2014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A. B. Lassman","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057541817"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"2014","last_page":"2014"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anaplastic-oligodendroglioma","display_name":"anaplastic oligodendroglioma","score":0.9679999947547913},{"id":"https://openalex.org/keywords/newly-diagnosed-glioma","display_name":"newly diagnosed glioma","score":0.6039999723434448},{"id":"https://openalex.org/keywords/procarbazine-lomustine-and-vincristine","display_name":"procarbazine, lomustine, and vincristine","score":0.8370000123977661},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9440000057220459},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.8119999766349792},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.5630000233650208},{"id":"https://openalex.org/keywords/1p-19q-codeletion","display_name":"1p/19q codeletion","score":0.9010000228881836},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8029999732971191},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9440000057220459},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.781000018119812},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.5400000214576721},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9357324242591858},{"id":"https://openalex.org/C2779434656","wikidata":"https://www.wikidata.org/wiki/Q415378","display_name":"Lomustine","level":5,"score":0.8540898561477661},{"id":"https://openalex.org/C2779112685","wikidata":"https://www.wikidata.org/wiki/Q418656","display_name":"Procarbazine","level":5,"score":0.8137201070785522},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.7022766470909119},{"id":"https://openalex.org/C2910969760","wikidata":"https://www.wikidata.org/wiki/Q1318384","display_name":"Oligodendroglial Tumor","level":5,"score":0.6937372088432312},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6090764403343201},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5653864145278931},{"id":"https://openalex.org/C2777931997","wikidata":"https://www.wikidata.org/wiki/Q1318384","display_name":"Oligodendroglioma","level":4,"score":0.5261989235877991},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.517322301864624},{"id":"https://openalex.org/C2779083369","wikidata":"https://www.wikidata.org/wiki/Q486092","display_name":"Anaplastic astrocytoma","level":4,"score":0.5127569437026978},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.441516637802124},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.43677008152008057},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4260144531726837},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.42385903000831604},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4035305976867676},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39530035853385925},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.2967231273651123},{"id":"https://openalex.org/C2778880634","wikidata":"https://www.wikidata.org/wiki/Q177755","display_name":"Astrocytoma","level":3,"score":0.1889837682247162},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.15810337662696838},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.2014","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.2014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2106824860","https://openalex.org/W2338824946","https://openalex.org/W2110700778","https://openalex.org/W2298377862","https://openalex.org/W1752140870","https://openalex.org/W1988089466","https://openalex.org/W2556783232","https://openalex.org/W4416336986","https://openalex.org/W1509193935","https://openalex.org/W2539147613"],"abstract_inverted_index":{"2014":[0],"Background:":[1],"Treatment":[2,118,349],"of":[3,11,75,170,194,270],"anaplastic":[4,61],"oligodendroglial":[5],"tumors":[6],"is":[7,36],"controversial.":[8],"Early":[9],"results":[10,280],"randomized":[12],"trials":[13],"suggest":[14],"chemotherapy":[15,131],"(CT)":[16],"with":[17,51,58,97,113,116,166,258,318],"procarbazine-lomustine-vincristine":[18],"(PCV)":[19],"before":[20],"or":[21,45,64,78,149,229],"after":[22],"radiotherapy":[23],"(RT)":[24],"improves":[25],"progression-free":[26],"but":[27,241,333],"not":[28,245,335,356],"overall":[29],"survival":[30],"(OS)":[31],"versus":[32,43,272,361],"RT":[33,123,129,134,146],"alone.":[34],"It":[35],"unknown":[37],"if":[38,46],"CT":[39,136,140,144,232,259,273,353],"alone":[40,124,141,233,260,304,312,354],"affects":[41],"outcome":[42],"CT&RT,":[44],"temozolomide":[47],"(TMZ)":[48],"compares":[49],"favorably":[50],"PCV.":[52],"Methods:":[53],"We":[54],"retrospectively":[55],"identified":[56],"adults":[57],"newly":[59],"diagnosed":[60],"oligodendroglioma":[62],"(AO)":[63],"oligo-astrocytoma":[65],"(AOA)":[66],"seen":[67],"at":[68],"17":[69],"medical":[70],"centers":[71],"from":[72],"1981\u20132007":[73],"exclusive":[74],"phase":[76],"III":[77],"bone":[79],"marrow":[80],"transplant":[81],"trials.":[82],"Data":[83],"were":[84,90,101,160],"updated":[85],"January":[86],"1,":[87],"2009.":[88],"Survivals":[89],"estimated":[91],"by":[92],"Kaplan-Meier":[93],"method":[94],"and":[95,158,162,188,213,373],"compared":[96],"log-rank.":[98],"Results:":[99],"There":[100],"1054":[102],"patients:":[103],"594":[104],"men,":[105],"460":[106],"women;":[107],"median":[108,167,201,242,323],"age":[109],"42":[110],"(18\u201388);":[111],"661":[112],"AO,":[114],"443":[115],"AOA.":[117],"was:":[119],"observation":[120],"(82,":[121],"8%),":[122],"(n":[125,177],"=":[126,178,211,239,252,288,296,308,316,340],"210,":[127],"20%),":[128],"then":[130,145],"(283,":[132],"27%),":[133],"+":[135],"concurrently":[137],"(118,":[138],"11%),":[139],"(205,":[142],"19%),":[143],"(137,":[147],"13%),":[148],"other":[150],"(19,":[151],"2%).":[152],"Median":[153,222,298],"time":[154],"to":[155,274,358,369],"progression":[156],"(TTP)":[157],"OS":[159,214,243,290,324,360],"2.8":[161],"6.5":[163],"years,":[164,218,237,250,286,294,306,314],"respectively,":[165],"follow":[168],"up":[169],"4.1":[171],"years":[172,206],"(0.03\u201320.8)":[173],"on":[174],"surviving":[175],"patients":[176],"560,":[179],"53%).":[180],"1p19q":[181,344,375],"co-deletion":[182,254,276,319,345],"was":[183,224,255,300,325],"observed":[184],"in":[185,191,367,378],"292":[186],"(48%)":[187],"no":[189,208],"deletion":[190],"232":[192],"(38%)":[193],"606":[195],"tested":[196],"tumors.":[197],"Co-deletion":[198],"predicted":[199,346],"longer":[200,225,301,327],"TTP":[202,223,282,299],"(4.2":[203],"vs.":[204,216,235,248,284,292,330],"1.8":[205],"for":[207],"deletion,":[209],"p":[210,219,238,251,287,295],"0.0002)":[212],"(8.4":[215],"3.3":[217],"<":[220,264,321],"0.0001).":[221],"following":[226,302],"CT&RT":[227,262,271],"(sequential":[228],"concurrent)":[230],"than":[231,261,310],"(3.7":[234],"2.6":[236],"0.0007),":[240],"did":[244,334,355],"differ":[246],"(6.6":[247],"7.1":[249,331],"0.8);":[253],"more":[256],"common":[257],"(p":[263,320,339],"0.0001,":[265],"\u03c72),":[266],"although":[267],"restricting":[268],"analysis":[269],"the":[275],"cohort":[277],"yielded":[278],"analogous":[279],"(median":[281],"7.2":[283],"3.8":[285],"0.011;":[289],"7.9":[291],"10.4":[293],"0.26).":[297],"PCV":[303,363],"(7.6":[305],"n":[307,315],"17)":[309],"TMZ":[311],"(3.3":[313],"65)":[317],"0.02);":[322],"also":[326],"(not":[328],"reached,":[329],"years),":[332],"reach":[336],"statistical":[337],"significance":[338],"0.07":[341],"log-rank).":[342],"Conclusions:":[343],"improved":[347],"outcome.":[348],"strategies":[350],"varied":[351],"widely.":[352],"appear":[357],"shorten":[359],"CT&RT.":[362],"may":[364],"be":[365],"superior":[366],"efficacy":[368],"TMZ.":[370],"Multivariate":[371],"analyses":[372],"additional":[374],"testing":[376],"are":[377],"progress.":[379],"[Table:":[380],"see":[381],"text]":[382]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}